CollPlant broadens collaboration with STEMCELL Technologies
2025-06-09 07:40:36 ET
More on CollPlant Biotechnologies
- CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript
- CollPlant Biotechnologies shares slide after announces capital raise of $3.6M through registered direct offering
- Collplant plans clinical trials for dermal filler and advances regenerative implants
- Seeking Alpha’s Quant Rating on CollPlant Biotechnologies
- Historical earnings data for CollPlant Biotechnologies
Read the full article on Seeking Alpha
For further details see:
CollPlant broadens collaboration with STEMCELL TechnologiesNASDAQ: CLGN
CLGN Trading
-1.9% G/L:
$0.6082 Last:
18,795 Volume:
$0.6001 Open:



